A Study of [14C]Ulonivirine ([14C]MK-8507) in Healthy Adults (MK-8507-006)
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Merck Sharp & Dohme LLC
Related studies linked through entity extraction aliases.
A Clinical Trial to Compare Forms of MK-1167 in Healthy People (MK-1167-011)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Phase Ib/II Study of ATG-022 Plus Pembrolizumab With/Without Chemotherapy in Participants With Claudin (CLDN) 18.2-positive, HER2-negative, Unresectable or Metastatic Gastric or Gastroesophageal Junction AdenocarcinomaUnresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Cancer (MK-2870-021)
- Status
- RECRUITING
- Phase
- PHASE3
A Clinical Trial to Evaluate the Effect of Ulonivirine (MK-8507) on Heart Rhythm in Healthy Adults (MK-8507-012)
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Pembrolizumab in Japanese Pediatric Participants With Solid Tumors or Lymphomas and Japanese Adult Participants With Merkel Cell Carcinoma (MK-3475-G21/KEYNOTE-G21)
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Clinical Trial of Enlicitide and Rosuvastatin in Healthy Adults (MK-0616-039)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Clinical Study of Novel Pneumococcal Vaccine V118C in Children (V118C-002)
- Status
- RECRUITING
- Phase
- PHASE1
A Clinical Study of MK-1084 With Other Treatments for Non-small Cell Lung Cancer (MK-3475-01F)
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Preoperative Chemotherapy, Pembrolizumab and Low or High Dose RADiation in an Expansion Cohort of Node(+), Triple Negative Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Pembrolizumab + MRGOO3 as Neoadjuvant in NPC
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
A Clinical Study of Islatravir and Ulonivirine for People With HIV-1 Who Have Not Been Treated Before (MK-8591B-062)
- Status
- RECRUITING
- Phase
- PHASE2/PHASE3
A Clinical Trial of MK-1167 in Healthy Adults (MK-1167-010)
- Status
- COMPLETED
- Phase
- PHASE1
EIK1005-002: A Clinical Research Study Evaluating EIK1005, a Werner Helicase Inhibitor, as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors Including Microsatellite Instability High (MSI-H) Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
KEYMAKER-U01 Substudy 01J: A Study of Pembrolizumab Plus MK-1084 in Participants With Non-Small Cell Lung Cancer (NSCLC) With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) G12C Mutations (MK-3475-01J/KEYMAKER-U01J)
- Status
- RECRUITING
- Phase
- PHASE2
Respiratory Infections in Young Children
- Status
- RECRUITING
- Phase
- N/A
A Clinical Study of MK-4716 in People With Certain Solid Tumors (MK-4716-001)
- Status
- RECRUITING
- Phase
- PHASE1
Lutetium (177Lu) DGUL Combined With Pembrolizumab in Metastatic Castration-Resistant Prostate Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
A Clinical Trial of MK-1403 in Participants With Type 2 Diabetes Mellitus (MK-1403-006)
- Status
- RECRUITING
- Phase
- PHASE1
KEYMAKER-U04 Substudy 04D: A Clinical Study of New Treatments Given With Enfortumab Vedotin and Pembrolizumab in People With Urothelial Cancer (MK-3475-04D/KEYMAKER-U04)
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2